Wellington Partners is a pan-European venture capital firm founded in 1998, with offices in London, Munich, and Zurich. The firm specializes in early- and growth-stage investments, primarily in the life sciences sector, including therapeutics, medical devices, diagnostics, digital health, and industrial biotechnology. With over €590 million raised for life science funds and 27 life science exits, IPOs, and trade sales, Wellington Partners has a strong track record in supporting innovative companies.